Hugues Moreau

Hugues Moreau is a notable inventor based in Luce, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of mesalamine suppositories. With a total of 2 patents to his name, Moreau's work focuses on improving patient comfort and treatment efficacy.

Latest Patents

One of Hugues Moreau's latest patents is a mesalamine rectal suppository designed to provide improved comfort of use. This invention includes a formulation comprising mesalamine and one or more pharmaceutically acceptable excipients, with a drug load ranging from 35% to 50%. Another embodiment of this invention features mesalamine with a tap density between 600 to 800 g/L, combined with a hard fat that has a melting point of 32 to 35.5°C. Additionally, the suppository includes mesalamine particles with a surface area ranging from 0.1 m/g to 2.8 m/g. The patent also outlines methods for preparing these suppositories and determining their dissolution parameters.

Career Highlights

Hugues Moreau has worked with reputable companies in the pharmaceutical industry, including Aptalis Pharma Canada Inc. and Aptalis Pharma Canada Ulc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of Hugues Moreau's notable coworkers include Carl Gauthier and Yves Dumoulin. Their collaboration has likely played a role in advancing the research and development of mesalamine formulations.

Conclusion

Hugues Moreau's contributions to the field of pharmaceuticals, particularly through his innovative mesalamine suppositories, highlight his commitment to improving patient care. His work continues to influence the development of effective treatment options in the industry.